Die [Nicotinamid-ribofuranosyl]-[w-(adenin-9-yl)-n-alkyl]-pyrophosphate 1-41)werden durch Kondensation der ~~(Adenin-9-yl)-n-aIkyl-phosphate mit Nicotinamidmononucleotid gewonnen. Die Coenzymanalogen zeigen nahezu gleiche physikalische und chemische Eigenschaften wie Nicotinamid-adenin-dinucleotid (NAD 2)
Interactions of the Nonfunctional Coenzyme Binding Site in Dehydrogenases with [Nicotinamide-ribofuranosyl] [w-(Adenine-9-yl)-n-alkyl] PyrophosphatesThe [nicotinamide-ribofuranosyl] [o>-(adenine-9-yl)-n-alkyl] pyrophosphates 1-41) are obtained by condensation of ct~-(adenine-9-yl)-n-alkyl phosphates with nicotinamide mononucleotide. The coenzyme analogues show nearly identical physical and chemical properties as nicotinamide-adenine dinucleotide (NAD)2). The intramolecular interaction between adenine and the quaternary nicotinamide system is less compared to NADe and depends on the length of the hydrocarbon chains which in the models connect the adenine ring to the pyrophosphate *) Korrespondenz bitte an diesen Autor richten. 1) 1: n-alkyl = athyl, 2 : n-alkyl = n-propyl, 3: n-alkyl = n-butyl und 4: n-alkyl = n-pentyl. NAD-Oxidoreduktase (EC 1.1.1.37); Glutamat-Dehydrogenase = L-Glutamat: NAD(P)-Oxidoreduktase (desaminierend) (EC 1.4.1.3) ; Pyrophosphatase aus Nuju Niveu36) = Dinucleotid-nucleotidhydrolase (EC 3.6.1.9) ; NADo = Nicotinamid-adenin-dinucleotid, NADH = Dihydronicotinamid-adenin-dinucleotid.